A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology
Courtney M. Tate(Eli Lilly (United States)), Louis F. Stancato(Eli Lilly (United States))
Cited by 18
Related Papers
LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer
|Oncotarget|2016|68
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
|Cell Death and Differentiation|2012|65